8:40am ET
Investing
J.P. Morgan’s Top Stock Picks for the Second Half of 2014
A new report from the equity strategy team at J.P. Morgan presents an extensive list of top names to buy for the next six months in a multitude of categories.
Companies
/Healthcare
Biomarin Pharmaceutical Inc
$65.36
▼ $0.25 (−0.38%) today
Markets open · 3:47pm ET
BMRN Coverage
Page 10
8:30am ET
Investing
Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple, Hewlett-Packard, Qualcomm and Sprouts Farmers Market.
8:30am ET
Health and Healthcare
Top Biotech Stocks for Cancer Cures From Cowen
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the…
8:50am ET
Health and Healthcare
UBS Top Stocks to Buy Working for Cancer Cures
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of…
8:00am ET
Health and Healthcare
Who Bucked the Short Interest Trend in Biotech Stocks?
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many of them.…
7:55am ET
Investing
Top Analyst Upgrades and Downgrades: Arch Coal, BlackBerry, Himax, Palo Alto, Varonis and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, March 25, 2014. They include Arch Coal, BlackBerry, Himax Technologies, Palo Alto Networks and Varonis…
7:00am ET
Health and Healthcare
Short Sellers Return to Biotech Stocks
After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical stocks in early February. The largest upswings happened to BioMarin Pharmaceutical and…
9:05am ET
Health and Healthcare
Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside
Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we focused on the quality large cap names and the stocks with the…
8:15am ET
Health and Healthcare
UBS Has Nine Biotech Buyout and Merger Candidates
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this…
8:10am ET
Health and Healthcare
J.P. Morgan Top Biotechnology Stocks to Buy for 2014
Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going forward but can stay intact. They think the fundamental backdrop is very…
8:30am ET
Health and Healthcare
Cowen Forecasts Top 10 Potential Biotech Surprises for 2014
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
11:50am ET
Investing
Top Biotechs Set to Win in the War on Cancer
ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech analysts at…
8:45am ET
Health and Healthcare
Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?
ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company has now…
8:10am ET
Health and Healthcare
PropThink Biotech Stocks With Big Upside Potential
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise is the difference…
8:30am ET
Retail
Top Wall Street Analyst Upgrades: Arch Coal, Gap, BioMarin and More
Investors and traders seem to be constantly looking for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many research calls each day to find…